RYLAN CHAN: Open Payments
NPI 1306874623 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 95 payments from 27 companies in 2025. Trend: 2023 $1,656 · 2024 $2,007 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $211 |
| Novo Nordisk Inc | 14 | $183 |
| PFIZER INC. | 11 | $179 |
| Amgen Inc. | 10 | $146 |
| ABBVIE INC. | 10 | $137 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 3 | $56 |
Products named: BREZTRI, NURTEC ODT, REPATHA, REXULTI, UBRELVY, EVENITY, Rybelsus, Wegovy.
Industry payments across ID — which companies pay providers there.
